澳门大阳城122.ccapp官方下载

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Biophysical studies of bacterial topoisomerases substantiate their binding modes to an inhibitor

biophysical. 2015-10; 
Author links open overlay panelCongBaoKang,YanLi,JosephCherian,BopingLiu,Hui QiNg,Michelle YueqiLee,Nur HudaBinte Ahmad,Zhi YingPoh,Yun XuanWong,QiweiHuang,Ying LeiWong,Alvin W.Hung,JeffreyHill,Thomas H.Keller
Products/Services Used Details Operation
Gene Synthesis … COVID-19 campus closures … relied on available GyrB/ParE x-ray structures from Escherichia coli and Streptococcus pneumonia (S. pn) (12, 13, 18, 19, 20, 21 … cDNA encoding sParE encompassing residues 1–228 of the E-subunit of Topo IV of S. pn was synthesized by Genscript Get A Quote

摘要

Bacterial DNA topoisomerases are essential for bacterial growth and are attractive, important targets for developing antibacterial drugs. Consequently, different potent inhibitors that target bacterial topoisomerases have been developed. However, the development of potent broad-spectrum inhibitors against both Gram-positive (G+) and Gram-negative (G-) bacteria has proven challenging. In this study, we carried out biophysical studies to better understand the molecular interactions between a potent bis-pyridylurea inhibitor and the active domains of the E-subunits of topoisomerase IV (ParE) from a G+ strain (Streptococcus pneumoniae (sParE)) and a G- strain (Pseudomonas aeruginosa (pParE)). NMR results demonstrat... More

关键词